A molecular docking analysis using AutoDock Vina software demonstrated the stable binding of WPPNYQW to the active sites of overexpressed EGFR, PI3K, AKT1, and CDK4 proteins in breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.